| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10817687 | Clinical Biochemistry | 2014 | 11 Pages |
Abstract
As populations age and effective treatments and interventions for coronary artery disease improve, heart failure will increase in incidence and prevalence. Blood biomarkers will play an increasing role in the early diagnosis, therapeutic monitoring and management of heart failure patients in the future.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Michael E. Liquori, Robert H. Christenson, Paul O. Collinson, Christopher R. deFilippi,